Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: Possibilities for prevention

Mutation Research - Reviews in Mutation Research

Volumn 659, Issue 1-2, 2008, Pages 176-184

  Anwar, Wagida A ^a   Khaled, Hussein M ^b   Amra, Hassan A ^c   El Nezami, Hani ^d   Loffredo, Christopher A ^e  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

Aflatoxins; HBV; HCV; Hepatocellular carcinoma; Prevalence; Prevention; Risk factors

Indexed keywords

AFLATOXIN; AFLATOXIN B1; AFLATOXIN M1; PESTICIDE;

BLOOD TRANSFUSION; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CIRCUMCISION; CULTURAL FACTOR; DENTAL CARE; EGYPT; ENDEMIC DISEASE; ENVIRONMENTAL FACTOR; EPIDEMIC; FOOD INTAKE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; OBESITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHISTOSOMIASIS; SMOKING; SUPERINFECTION; VEIN CATHETERIZATION; VIRUS TRANSMISSION;

AFLATOXINS; CARCINOMA, HEPATOCELLULAR; EGYPT; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER NEOPLASMS; PESTICIDES; PUBLIC HEALTH; RISK FACTORS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; ZEA MAYS;

EID: 47849123987     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2008.01.005     Document Type: Review

References (50)

1. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000: the global picture. Eur. J. Cancer 37 Suppl. 8 (2001) S4-S66
2. Kirk G.D., Bah E., and Montesano R. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 27 10 (2006) 2070-2082
3. Velazquez R.E., Rodriguez M., Navascues C.A., Linares A., Perez R., Sotorrios N.G., Martinez I., and Rodrigo L. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37 (2003) 520-527
4. El-Serag H.B. Hepatocellular carcinoma: an epidemiologic view. J. Clin. Gastroenterol. 35 Suppl. 2 (2002) S72-S78
5. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., Christensen E., Pagliaro L., Colombo M., and Rodes J. EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. J. Hepatol. 35 (2001) 421-430
6. Inas Elattar, Website of the National Cancer Institute, Egypt: http://www.nci.edu.eg (2003).
7. Ohata K., Hamasaki K., Toriyama K., Ishikawa H., Nakao K., and Eguchi K. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 19 (2004) 670-675
8. Xiong J., Yao Y.C., Zi X.Y., Li J.X., Wang X.M., Ye X.T., Zhao S.M., Yan Y.B., Yu H.Y., and Hu Y.P. Expression of hepatitis B virus X protein in transgenic mice. World J. Gastroenterol. 9 (2003) 112-116
9. Pisani P., Parkin D.M., Munoz N., and Ferlay J. Cancer and infection: estimates of the attributable fraction in. Cancer Epidemiol. Biomarkers Prev. 6 (1997) 387-400 (1990)
10. Yates S.C., Hafez M., Beld M., Lukashov V.V., Hassan Z., Carboni G., Khaled H., McMorrow M., Attia M., and Goudsmit J. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level. Am. J. Trop. Med. Hyg. 60 (1999) 714-720
11. El-Zayadi A., Rahman, Abaza H., Shawky S., Mohamed M.K., Selim O.E., and Badran H.M. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single center experience. Hepatol. Res. 19 (2001) 170-179
12. Liang T.J., Rustgi V., Galun E., and Blum H.E. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18 (1993) 1326-1333
13. El-Nady G.M., Ling R., and Harrison T.J. Gene expression in HCV-associated hepatocellular carcinoma-upregulation of a gene encoding a protein related to the ubiquitin-conjugating enzyme. Liver Int. 23 (2003) 329-337
14. Bosch F.X., Ribes J., and Borras J. Epidemiology of primary liver cancer. Semin. Liver Dis. 19 (1999) 271-285
15. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin. Liver Dis. 19 (1999) 263-269
16. Szab E., Paska C., Kaposi Novak P., Schaff Z., and Kiss A. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol. Oncol. Res. 1 (2004) 5-11
17. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology 45 Suppl. 3 (1998) 1206-1213
18. Nadia M., Iman G., and Iman A. Cancer Pathology Registry: 2003-2004, and Time Trend Analysis (2007), National Cancer Institute, Cairo University
19. El-Zayadi A.R., Badran H.M., Barakat E.M.F., Attia M.E.D., Shawky S., Mohamed M.K., Selim O., and Saeid A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J. Gastroenterol. 11 33 (2005) 5193-5198
20. Mostafa K. Epidemiology of HCV in Egypt. Afro-Arab Liver J. 3 2 (2004) 41-52
21. El-Serag H.B. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 5 (2001) 87-107
22. Hassan M.M., Zaghloul A.S., El-Serag H.B., Soliman O., Patt Y.Z., Chappell C.L., Beasley R.P., and Hwang L.Y. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J. Clin. Gastroenterol. 33 2 (2001) 123-126
23. Ezzat S., Abdel-Hamid M., Eissa S.A., Mokhtar N., Labib N.A., El-Ghorory L., Mikhail N.N., Abdel-Hamid A., Hifnawy T., Strickland G.T., and Loffredo C.A. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int. J. Hyg. Environ. Health 208 5 (2005) 329-339
24. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R., Magder L.S., El Khoby T., Abdel-Wahab Y., Ohn E.A., Anwar W., and Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C in Egypt. Lancet 355 (2000) 887-891
25. Ghaffar Y.A., Fattah S.A., Kamel M., Badr R.M., Mahomed F.F., and Strickland G.T. The impact of endemic schistosomiasis on acute viral hepatitis. Am. J. Trop. Med. Hyg. 45 (1991) 743-750
26. Taha El Khoby. Schistosomiasis in Egypt. Am. J. Trop. Med. Hyg. 62 (2000) 88-99
27. WHO Global surveillance, control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral. Hepat. 6, 35-47 (1999).
28. Heintges T., and Wands J.R. Hepatitis C virus: epidemiology and transmission. Hepatology 26 (1997) 521-526
29. Ray S.C., Arther R.R., Carella A., Bukh J., and Thomas D.L. Genetic epidemiology of hepatitis C virus throughout Egypt. J. Infect. Dis. 182 3 (2000) 698
30. Tanaka Y., Agha S., Saudy N., Kubanov F., Orito E., Kato T., Abo-Zeid M., Khalaf M., Miyakawa Y., and Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J. Mol. Evol. 58 2 (2004) 191
31. M. Abdel-Hamid, M. El-Daly, V. Molnegren, S. El-Kafrawy, S. Abdel-Latif, G. Esmat, G.T. Strickland, C. Loffredo, J. Albert, A. Widell, Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J. Gen. Virol. 88, 1526-1531 (2007).
32. El Gaafary M.M., Rekacewicz C., Abdel-Rahman A.G., Allam M.F., El Hosseiny M., Abdel Hamid M., Colombani F., Sultan Y., EI-Aidy S., Fontanet A., and Mohamed M.I. Surveillance of acute hepatitis C in Cairo. Egypt. J. Med. Virol. 76 (2005) 520-525
33. Pybus O.G., Drummond A.J., Nakano T., Robertson B.H., and Rambaut A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20 3 (2003) 381-387
34. International Agency for Research on Cancer. IARC' S7. Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity. 440 pp. Lyon, France (1987).
35. M.K. Mohamed, A.R. El Zayadi, S.A. Anoun, H. Abaza, O.E. Selim, H.M. Badran, G.T. Strickland, Trend of hepatocellular carcinoma and associated risk factor in Egypt in the Pan Arab Association of Gastroentrology 12-16 September Egypt (Abstract) (1999).
36. El-Kafrawy S.A., Abdel-Hamid M., El-Daly M., Nada O., Ismail A., Ezzat S., Abdel-Latif S., Abdel-Hamid A., Shields P.G., and Loffredo C. P53 mutations in hepatocellular carcinoma patients in Egypt. Int. J. Hyg. Environ. Health 208 4 (2005) 263-270
37. Hifnawy M.S., Mangoud A.M., Eissa M.H., Nor Edin E., Mostafa Y., Abouel-Magd Y., Sabee E.I., Amin I., Ismail A., Morsy T.A., Mahrous S., Afefy A.F., el-Shorbagy E., el-Sadawy M., Ragab H., Hassan M.I., el-Hady G., and Saber M. The role of aflatoxin-contaminated food materials and HCV in developing hepatocellular carcinoma in Al-Sharkia Governorate. Egypt. J. Egypt Soc. Parasitol. 34 Suppl. 1 (2004) 479-488
38. Amra H.A., Masheal S.F., Ebba M.M., Bakr A.A., Nogaim Q.A., and Anwar W.A. Aflatoxins level in some Egyptian crops collected from different governorates: possibilities for detection and prevention (Poster No. 26). 5th International Conference on Environmental Mutagens in Human Populations: "Identification of Environmental Hazards and Promotion of Health". Antalya, Turkey, 20-24, May (2007)
39. Polychronaki N., Turner C.P., Mykkanen H., Gong Y., Amra H., Abdel-Wahhab M., and El-Nezami H. Determinants of aflatoxin M1 in breast milk in a selected group of Egyptian mothers. Food Addit. Contam. 23 7 (2006) 700-708
40. Polychronaki N., West R.M., Turner P.C., Amra H., Abdel-Wahhab M., Mykkanen H., and El-Nezami H. A longitudinal assessment of aflatoxin M(1) excretion in breast milk of selected Egyptian mothers. Food Chem. Toxicol. 45 7 (2007) 1210-1215
41. Hassan A.M., Sheashaa H.A., Abdel Fatah M.F., Ibrahim A.Z., and Gaber O.A. Does aflatoxin as an environmental mycotoxin adversely affect the renal and hepatic functions of Egyptian lactating mothers and their infants? A preliminary report. Int. Urol. Nephrol. 38 2 (2006) 339-342
42. Kao J.H., and Chen D.S. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2 (2002) 395-403
43. Kirk G.D. Hepatitis B vaccination and liver cancer. In: Stewart B.W., and Kleihues P. (Eds). World Cancer Report (2003), IARC Press, Lyon 144-147
44. Carlson M.A., Bargeron C.B., Benson R.C., Fraser A.B., Phillips T.E., Velky J.T., Groopman J.D., Strickland P.T., and Ko H.W. An automated, handheld biosensor for aflatoxin. Biosens. Bioelectron. 14 (2000) 841-848
45. Kensler T.W., Egner P.A., Wang J.B., et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology 127 (2004) S310-S318
46. Gratz S., Mykkanen H., and El-Nezami H. Aflatoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo. J. Food Protect. 68 11 (2005) 2470-2474
47. El-Nezami H.S., Polychronaki N.N., Ma J., Zhu H., Ling W., Salminen E.K., Juvonen R.O., Salminen S.J., Poussa T., and Mykkänen H.M. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am. J. Clin. Nutr. 83 5 (2006) 1199-1203
48. Montesano R., Hainaut P., and Wild C.P. Hepatocellular carcinoma: from gene to public health. J. Natl Cancer Inst. 89 (1997) 1844-1851
49. Wild C.P., Law G.R., and Roman E. Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutat. Res. 499 (2002) 3-12
50. Hussain S.P., and Harris C.C. Molecular epidemiology of human cancer. Toxicol. Lett. 102/103 (1998) 219-225